XML 74 R63.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Guarantor and Non-Guarantor Financial Information, Comprehensive Income Statements (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME    
Net sales $ 388.0 $ 355.3
Cost of products sold:    
Cost of products sold, excluding depreciation and amortization and other items1 [1] 316.7 262.7
Depreciation and amortization 10.5 9.6
Selling, general, administrative, research and development [2] 23.6 23.7
Other operating charges, net 0.1 0.0
Total costs and expenses 350.9 296.0
Operating Income (Loss) 37.1 59.3
Other (expense) income:    
Interest (expense) income (5.6) (5.6)
Other income, net 0.1 0.8
Income before income taxes 31.6 54.5
Income tax provision (5.9) (18.5)
Earnings in equity of subsidiaries 0.0 0.0
Net income 25.7 36.0
Comprehensive income 17.4 37.3
Consolidating Adjustments    
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME    
Net sales (22.4) (20.8)
Cost of products sold:    
Cost of products sold, excluding depreciation and amortization and other items1 (21.8) (20.1)
Depreciation and amortization 0.0 0.0
Selling, general, administrative, research and development (0.7) (0.5)
Other operating charges, net 0.0  
Total costs and expenses (22.5) (20.6)
Operating Income (Loss) 0.1 (0.2)
Other (expense) income:    
Interest (expense) income 0.1 0.0
Other income, net (0.1) 0.0
Income before income taxes 0.1 (0.2)
Income tax provision 1.5 2.5
Earnings in equity of subsidiaries (32.7) (43.2)
Net income (31.1) (40.9)
Comprehensive income (22.8) (42.2)
Parent    
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME    
Net sales 0.0 0.0
Cost of products sold:    
Cost of products sold, excluding depreciation and amortization and other items1 0.0 0.0
Depreciation and amortization 0.0 0.0
Selling, general, administrative, research and development 1.1 0.9
Other operating charges, net 0.0  
Total costs and expenses 1.1 0.9
Operating Income (Loss) (1.1) (0.9)
Other (expense) income:    
Interest (expense) income (5.2) (5.7)
Other income, net 0.0 0.0
Income before income taxes (6.3) (6.6)
Income tax provision 0.0 0.0
Earnings in equity of subsidiaries 32.0 42.6
Net income 25.7 36.0
Comprehensive income 17.4 37.3
Guarantor Subsidiaries    
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME    
Net sales 377.9 346.8
Cost of products sold:    
Cost of products sold, excluding depreciation and amortization and other items1 309.4 257.5
Depreciation and amortization 9.9 9.0
Selling, general, administrative, research and development 21.3 20.9
Other operating charges, net 0.1  
Total costs and expenses 340.7 287.4
Operating Income (Loss) 37.2 59.4
Other (expense) income:    
Interest (expense) income (0.5) 0.1
Other income, net 0.1 0.8
Income before income taxes 36.8 60.3
Income tax provision (7.1) (20.8)
Earnings in equity of subsidiaries 0.7 0.6
Net income 30.4 40.1
Comprehensive income 22.1 41.4
Non-Guarantor Subsidiaries    
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME    
Net sales 32.5 29.3
Cost of products sold:    
Cost of products sold, excluding depreciation and amortization and other items1 29.1 25.3
Depreciation and amortization 0.6 0.6
Selling, general, administrative, research and development 1.9 2.4
Other operating charges, net 0.0  
Total costs and expenses 31.6 28.3
Operating Income (Loss) 0.9 1.0
Other (expense) income:    
Interest (expense) income 0.0 0.0
Other income, net 0.1 0.0
Income before income taxes 1.0 1.0
Income tax provision (0.3) (0.2)
Earnings in equity of subsidiaries 0.0 0.0
Net income 0.7 0.8
Comprehensive income $ 0.7 $ 0.8
[1] See Note 4 for discussion of our adoption of ASU 2017-12 (as defined in Note 1) and the related reclassification of amounts previously presented in the Statements of Consolidated Income within Unrealized (gain) loss on derivative instruments and now included within Cost of products sold, excluding depreciation and amortization and other items.
[2] See Note 1 for discussion of our adoption of ASU 2017-07 (as defined in Note 1) and the related reclassification of amounts previously presented in the Statements of Consolidated Income within Selling, general, administrative, research and development and now included within Other (expense) income.